Trends in the prevalence of kidney stones in the United States from 2007 to 2016
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hyams ES, Matlaga BR (2014) Economic impact of urinary stones. Transl Androl Urol 3(3):278–283. https://doi.org/10.3978/j.issn.2223-4683.2014.07.02
Rule AD, Krambeck AE, Lieske JC (2011) Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol 6(8):2069–2075. https://doi.org/10.2215/CJN.10651110
Li C-C, Chien T-M, Wu W-J, Huang C-N, Chou Y-H (2018) Uric acid stones increase the risk of chronic kidney disease. Urolithiasis 46(6):543–547. https://doi.org/10.1007/s00240-018-1050-1
Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC, Tonelli M (2012) Kidney stones and kidney function loss: a cohort study. BMJ (Clin Res Ed) 345:e5287. https://doi.org/10.1136/bmj.e5287
El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 7(9):1409–1415. https://doi.org/10.2215/CJN.03210312
Taylor EN, Feskanich D, Paik JM, Curhan GC (2016) Nephrolithiasis and risk of incident bone fracture. J Urol 195(5):1482–1486. https://doi.org/10.1016/j.juro.2015.12.069
Lu YM, Chien TM, Li CC, Chou YH, Wu WJ, Huang CN (2018) Urolithiasis is associated with the increased risk for osteoporosis: a nationwide 9-year follow-up study. Urol Sci 29(3):145–150. https://doi.org/10.4103/UROS.UROS_20_17
Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Samuel S, Klarenbach SW, Curhan GC, Tonelli M (2014) Kidney stones and cardiovascular events: a cohort study. Clin J Am Soc Nephrol 9(3):506–512. https://doi.org/10.2215/cjn.04960513
Cheungpasitporn W, Thongprayoon C, Mao MA, O’Corragain OA, Edmonds PJ, Erickson SB (2014) The risk of coronary heart disease in patients with kidney stones: a systematic review and meta-analysis. N Am J Med Sci 6(11):580–585. https://doi.org/10.4103/1947-2714.145477
Chen Z, Prosperi M, Bird VY (2018) Prevalence of kidney stones in the USA: the national health and nutrition evaluation survey. J Clin Urol. https://doi.org/10.1177/2051415818813820
Alelign T, Petros B (2018) Kidney stone disease: an update on current concepts. Adv Urol 2018:3068365. https://doi.org/10.1155/2018/3068365
Romero V, Akpinar H, Assimos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12(2–3):e86–e96
Howden L, Meyer J (2011) Age and Sex Composition:2010 2010 Census Briefs. U.S. Department of Commerce, United States Census Bureau
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930. https://doi.org/10.1210/jc.2011-0385
Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817–1823. https://doi.org/10.1046/j.1523-1755.2003.00917.x
Antonelli JA, Maalouf NM, Pearle MS, Lotan Y (2014) Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol 66(4):724–729. https://doi.org/10.1016/j.eururo.2014.06.036
Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America P (2012) Prevalence of kidney stones in the United States. Eur Urol 62(1):160–165. https://doi.org/10.1016/j.eururo.2012.03.052
Yoon Sung S, Gu Q, Nwankwo T, Wright Jacqueline D, Hong Y, Burt V (2015) Trends in blood pressure among adults with hypertension. Hypertension 65(1):54–61. https://doi.org/10.1161/HYPERTENSIONAHA.114.04012
Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL (2018) Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016. JAMA 319(16):1723–1725. https://doi.org/10.1001/jama.2018.3060
Palmer MK, Toth PP (2019) Trends in lipids, obesity, metabolic syndrome, and diabetes mellitus in the United States: an NHANES analysis (2003-2004 to 2013-2014). Obesity 27(2):309–314. https://doi.org/10.1002/oby.22370
Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK (2019) Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007–2016. Arthr Rheumatol 71(6):991–999. https://doi.org/10.1002/art.40807
Reinstatler L, Khaleel S, Pais VM Jr (2017) Association of pregnancy with stone formation among women in the United States: a NHANES Analysis 2007 to 2012. J Urol 198(2):389–393. https://doi.org/10.1016/j.juro.2017.02.3233
Taylor EN, Curhan GC (2007) Differences in 24-Hour urine composition between black and white women. J Am Soc Nephrol 18(2):654–659. https://doi.org/10.1681/asn.2006080854
Talati JJ, Haroon N, Trinchieri A (2012) Renal stone disease in different racial groups. In: Talati JJ, Tiselius H-G, Albala DM, Ye Z (eds) Urolithiasis: basic science and clinical practice. Springer, London, pp 107–110. https://doi.org/10.1007/978-1-4471-4387-1_14
Parks JH, Worcester EM, O’Connor RC, Coe FL (2003) Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int 63(1):255–265. https://doi.org/10.1046/j.1523-1755.2003.00725.x
Rodman JS, Mahler RJ (2000) Kidney stones as a manifestation of hypercalcemic disorders. Hyperparathyroidism and sarcoidosis. Urol Clin North Am 27(2):275–285
Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68(3):1230–1235. https://doi.org/10.1111/j.1523-1755.2005.00516.x
Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293(4):455–462. https://doi.org/10.1001/jama.293.4.455
Curhan GC, Willett WC, Speizer FE, Stampfer MJ (2001) Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59(6):2290–2298. https://doi.org/10.1046/j.1523-1755.2001.00746.x
Taylor EN, Curhan GC (2007) Oxalate Intake and the risk for nephrolithiasis. J Am Soc Nephrol 18(7):2198. https://doi.org/10.1681/ASN.2007020219
Mandel EI, Taylor EN, Curhan GC (2013) Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion. Clin J Am Soc Nephrol 8(6):901. https://doi.org/10.2215/CJN.07190712
Dahlhamer JM, Zammitti EP, Ward BW, Wheaton AG, Croft JB (2016) Prevalence of inflammatory bowel disease among adults aged ≥ 18 years — United States. MMWR Morb Mortal Wkly Rep 65:1166–1169
Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S (2017) Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag 20(1):6–12. https://doi.org/10.1089/pop.2015.0181
Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ (2015) Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA 313(19):1973–1974. https://doi.org/10.1001/jama.2015.4260
Yagisawa T, Ito F, Osaka Y, Amano H, Kobayashi C, Toma H (2001) The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis. J Urol 166(3):1078–1082
Soundararajan P, Mahesh R, Ramesh T, Begum VH (2006) Effect of Aerva lanata on calcium oxalate urolithiasis in rats. Indian J Exp Biol 44(12):981–986
Fan J, Chandhoke PS, Grampsas SA (1999) Role of sex hormones in experimental calcium oxalate nephrolithiasis. J Am Soc Nephrol 10(Suppl 14):S376–S380
Otunctemur A, Ozbek E, Cakir SS, Dursun M, Polat EC, Ozcan L, Besiroglu H (2015) Urolithiasis is associated with low serum testosterone levels in men. Arch Ital Urol Androl 87(1):83–86. https://doi.org/10.4081/aiua.2015.1.83
Polat EC, Ozcan L, Otunctemur A, Ozbek E (2016) Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels. Urolithiasis 44(5):409–413. https://doi.org/10.1007/s00240-016-0888-3
Wang C, Jackson G, Jones TH, Matsumoto AM, Nehra A, Perelman MA, Swerdloff RS, Traish A, Zitzmann M, Cunningham G (2011) Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care 34(7):1669–1675. https://doi.org/10.2337/dc10-2339
Tajar A, Forti G, O’Neill TW, Lee DM, Silman AJ, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Han TS, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Vanderschueren D, Huhtaniemi IT, Wu FC (2010) Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab 95(4):1810–1818. https://doi.org/10.1210/jc.2009-1796
Salam R, Kshetrimayum AS, Keisam R (2012) Testosterone and metabolic syndrome: The link. Indian J Endocrinol Metab 16:S12–S19. https://doi.org/10.4103/2230-8210.94248
Kohjimoto Y, Sasaki Y, Iguchi M, Matsumura N, Inagaki T, Hara I (2013) Association of metabolic syndrome traits and severity of kidney stones: results from a Nationwide Survey on urolithiasis in Japan. Am J Kidney Dis 61(6):923–929. https://doi.org/10.1053/j.ajkd.2012.12.028
Heller HJ, Sakhaee K, Moe OW, Pak CY (2002) Etiological role of estrogen status in renal stone formation. J Urol 168(5):1923–1927. https://doi.org/10.1097/01.ju.0000033907.21910.be
Zhao Z, Mai Z, Ou L, Duan X, Zeng G (2013) Serum estradiol and testosterone levels in kidney stones disease with and without calcium oxalate components in naturally postmenopausal women. PLoS ONE 8(9):e75513. https://doi.org/10.1371/journal.pone.0075513
Wilson C (2011) Estrogen and kidney stones. Nat Rev Endocrinol 7(1):3. https://doi.org/10.1038/nrendo.2010.206
Haley WE, Enders FT, Vaughan LE, Mehta RA, Thoman ME, Vrtiska TJ, Krambeck AE, Lieske JC, Rule AD (2016) Kidney function after the first kidney stone event. Mayo Clin Proc 91(12):1744–1752. https://doi.org/10.1016/j.mayocp.2016.08.014
Curhan GC, Taylor EN (2008) 24-h uric acid excretion and the risk of kidney stones. Kidney Int 73(4):489–496. https://doi.org/10.1038/sj.ki.5002708
Taylor EN, Curhan GC (2006) Diet and fluid prescription in stone disease. Kidney Int 70(5):835–839. https://doi.org/10.1038/sj.ki.5001656
Komleh K, Hada P, Pendse AK, Singh PP (1990) Zine, copper and manganese in serum, urine and stones. Int Urol Nephrol 22(2):113–118. https://doi.org/10.1007/BF02549826
Meyer JL, Angino EE (1977) The role of trace metals in calcium urolithiasis. Invest Urol 14(5):347–350
Ferraro PM, Gambaro G, Curhan GC, Taylor EN (2018) Intake of trace metals and the risk of incident kidney stones. J Urol 199(6):1534–1539. https://doi.org/10.1016/j.juro.2018.01.077
Johri N, Jaeger P, Ferraro PM, Shavit L, Nair D, Robertson WG, Gambaro G, Unwin RJ (2017) Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk? Urolithiasis 45(6):535–543. https://doi.org/10.1007/s00240-016-0954-x
Ferraro PM, Taylor EN, Gambaro G, Curhan GC (2017) Vitamin D intake and the risk of incident kidney stones. J Urol 197(2):405–410. https://doi.org/10.1016/j.juro.2016.08.084
Taylor EN, Hoofnagle AN, Curhan GC (2015) Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones. Clin J Am Soc Nephrol 10(4):667–675. https://doi.org/10.2215/cjn.07060714
Letavernier E, Daudon M (2018) Vitamin D, hypercalciuria and kidney stones. Nutrients 10(3):366. https://doi.org/10.3390/nu10030366
Tasian GE, Ross ME, Song L, Sas DJ, Keren R, Denburg MR, Chu DI, Copelovitch L, Saigal CS, Furth SL (2016) Annual incidence of nephrolithiasis among children and adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol 11(3):488. https://doi.org/10.2215/CJN.07610715
Kittanamongkolchai W, Vaughan LE, Enders FT, Dhondup T, Mehta RA, Krambeck AE, McCollough CH, Vrtiska TJ, Lieske JC, Rule AD (2018) The changing incidence and presentation of urinary stones over 3 decades. Mayo Clin Proc 93(3):291–299. https://doi.org/10.1016/j.mayocp.2017.11.018